tgen | Strategic Alliance Partners

Latest from tgen

Nab-Paclitaxel Boosts Survival in Pancreatic Cancer

December 04, 2013

The addition of albumin-bound paclitaxel (nab-paclitaxel; Abraxane) to standard treatment with gemcitabine significantly lengthens survival in patients with metastatic pancreatic cancer, researchers report.

New Indication Solidifies Nab-Paclitaxel Pancreatic Regimen

October 28, 2013

The ability of clinicians to improve treatment outcomes that gemcitabine offers for patients with metastatic pancreatic cancer is expected to move forward now that the FDA has approved a new indication for nab-paclitaxel (Abraxane) as part of a combination regimen, according to researchers.